Urinary Glucose on Jardiance (Empagliflozin): Expected and Acceptable Levels
Glucosuria (glucose in the urine) is the intended therapeutic effect of Jardiance, and patients should expect to excrete approximately 64-78 grams of glucose per day (roughly 3,500-4,300 mg/dL in spot urine samples), which is completely normal and acceptable while taking this medication 1.
Understanding the Mechanism
Jardiance works by blocking SGLT2 transporters in the kidney, which normally reabsorb glucose from urine back into the bloodstream. By inhibiting this reabsorption, the drug intentionally causes glucose to spill into the urine—this is not a sign of poor diabetes control but rather proof the medication is working 1.
Expected Urinary Glucose Levels
Quantitative Amounts:
- 10 mg dose: Approximately 64 grams of glucose excreted per 24 hours 1
- 25 mg dose: Approximately 78 grams of glucose excreted per 24 hours 1
Clinical Context:
- Urinary glucose excretion increases immediately after the first dose and is maintained throughout treatment 1
- The glucose threshold for spillage drops to below 40 mg/dL plasma glucose—well below normal fasting levels 2
- This means patients will have persistent glucosuria even when blood glucose is well-controlled 2
Duration of Effect
After stopping Jardiance, urinary glucose excretion returns to baseline approximately 3 days after the last dose for both 10 mg and 25 mg formulations 1. This information is useful if the medication needs to be discontinued before surgery or during acute illness.
Clinical Implications and Monitoring
What NOT to Do:
- Do not interpret positive urine glucose as treatment failure or poor glycemic control—this is the expected pharmacodynamic effect
- Do not use urine glucose testing to monitor diabetes control in patients on SGLT2 inhibitors; use blood glucose or HbA1c instead
Important Safety Considerations:
Genital Mycotic Infections: The high glucose content in urine creates an environment conducive to yeast infections, particularly in women. Counsel patients on genital hygiene and monitor for symptoms 3.
Volume Status: The initial diuretic effect (mean 341 mL increase on Day 1, decreasing to 135 mL by Day 5) requires attention to hydration status, especially in elderly patients or those on diuretics 1, 4.
DKA Risk: While rare in type 2 diabetes, the combination of glucosuria and insulin deficiency can precipitate euglycemic DKA. Discontinue 3-4 days before surgery and during acute illness 3.
Renal Function Considerations
The glucose-lowering effect diminishes significantly when eGFR falls below 45 mL/min/1.73 m², but the medication should be continued for cardiovascular and renal benefits until dialysis or transplantation 3. The glucosuria will naturally decrease as kidney function declines since less glucose is being filtered.
Bottom Line for Patient Counseling
Reassure patients that seeing glucose in their urine (if tested) or having positive urine dipsticks is expected and desired while taking Jardiance. This represents the medication working as intended to lower blood sugar by removing excess glucose through the kidneys. The typical patient will lose 50-100 grams of glucose daily in urine, equivalent to 200-400 calories per day, which contributes to the weight loss benefit of this medication 5.